Aurora Cannabis (ACB) EBITDA: 2018-2025
Historic EBITDA for Aurora Cannabis (ACB) over the last 7 years, with Sep 2025 value amounting to $2.8 million.
- Aurora Cannabis' EBITDA rose 262.53% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.4 million, marking a year-over-year increase of 166.78%. This contributed to the annual value of $3.4 million for FY2025, which is 110.30% up from last year.
- Aurora Cannabis' EBITDA amounted to $2.8 million in Q3 2025, which was up 362.20% from -$1.1 million recorded in Q2 2025.
- Aurora Cannabis' EBITDA's 5-year high stood at $26.4 million during Q4 2024, with a 5-year trough of -$112.9 million in Q1 2021.
- Over the past 3 years, Aurora Cannabis' median EBITDA value was -$1.7 million (recorded in 2024), while the average stood at -$2.4 million.
- Per our database at Business Quant, Aurora Cannabis' EBITDA soared by 304.13% in 2024 and then tumbled by 898.92% in 2025.
- Quarterly analysis of 5 years shows Aurora Cannabis' EBITDA stood at -$44.3 million in 2021, then declined by 11.43% to -$49.3 million in 2022, then soared by 73.79% to -$12.9 million in 2023, then skyrocketed by 304.13% to $26.4 million in 2024, then soared by 262.53% to $2.8 million in 2025.
- Its EBITDA stands at $2.8 million for Q3 2025, versus -$1.1 million for Q2 2025 and -$16.7 million for Q1 2025.